vs

Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and P10, Inc. (PX). Click either name above to swap in a different company.

COHEN & STEERS, INC. is the larger business by last-quarter revenue ($143.8M vs $81.0M, roughly 1.8× P10, Inc.). COHEN & STEERS, INC. runs the higher net margin — 24.3% vs 11.7%, a 12.6% gap on every dollar of revenue. On growth, COHEN & STEERS, INC. posted the faster year-over-year revenue change (2.9% vs -4.7%). P10, Inc. produced more free cash flow last quarter ($18.1M vs $-126.4M). Over the past eight quarters, P10, Inc.'s revenue compounded faster (10.7% CAGR vs 8.3%).

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

P10, Inc. is a global alternative investment management firm that offers a diversified portfolio of investment solutions spanning private equity, private credit, real assets and venture capital. It primarily caters to institutional clients including pension funds, endowments, foundations, and high-net-worth individuals across North America, Europe, and Asia Pacific.

CNS vs PX — Head-to-Head

Bigger by revenue
CNS
CNS
1.8× larger
CNS
$143.8M
$81.0M
PX
Growing faster (revenue YoY)
CNS
CNS
+7.5% gap
CNS
2.9%
-4.7%
PX
Higher net margin
CNS
CNS
12.6% more per $
CNS
24.3%
11.7%
PX
More free cash flow
PX
PX
$144.5M more FCF
PX
$18.1M
$-126.4M
CNS
Faster 2-yr revenue CAGR
PX
PX
Annualised
PX
10.7%
8.3%
CNS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNS
CNS
PX
PX
Revenue
$143.8M
$81.0M
Net Profit
$34.9M
$9.5M
Gross Margin
Operating Margin
28.0%
31.9%
Net Margin
24.3%
11.7%
Revenue YoY
2.9%
-4.7%
Net Profit YoY
-23.9%
79.0%
EPS (diluted)
$0.67
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNS
CNS
PX
PX
Q4 25
$143.8M
$81.0M
Q3 25
$141.7M
$75.9M
Q2 25
$136.1M
$72.7M
Q1 25
$134.5M
$67.7M
Q4 24
$139.8M
$85.0M
Q3 24
$133.2M
$74.2M
Q2 24
$121.7M
$71.1M
Q1 24
$122.7M
$66.1M
Net Profit
CNS
CNS
PX
PX
Q4 25
$34.9M
$9.5M
Q3 25
$41.7M
$2.1M
Q2 25
$36.8M
$3.4M
Q1 25
$39.8M
$4.5M
Q4 24
$45.8M
$5.3M
Q3 24
$39.7M
$1.4M
Q2 24
$31.8M
$7.0M
Q1 24
$34.0M
$5.0M
Operating Margin
CNS
CNS
PX
PX
Q4 25
28.0%
31.9%
Q3 25
34.5%
14.1%
Q2 25
31.8%
24.4%
Q1 25
33.6%
16.6%
Q4 24
35.3%
26.9%
Q3 24
33.7%
11.9%
Q2 24
31.5%
23.7%
Q1 24
32.8%
18.3%
Net Margin
CNS
CNS
PX
PX
Q4 25
24.3%
11.7%
Q3 25
29.4%
2.8%
Q2 25
27.1%
4.7%
Q1 25
29.6%
6.7%
Q4 24
32.8%
6.2%
Q3 24
29.8%
1.9%
Q2 24
26.1%
9.8%
Q1 24
27.7%
7.6%
EPS (diluted)
CNS
CNS
PX
PX
Q4 25
$0.67
$0.08
Q3 25
$0.81
$0.02
Q2 25
$0.72
$0.03
Q1 25
$0.77
$0.04
Q4 24
$0.89
$0.05
Q3 24
$0.77
$0.01
Q2 24
$0.63
$0.06
Q1 24
$0.68
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNS
CNS
PX
PX
Cash + ST InvestmentsLiquidity on hand
$145.5M
$28.2M
Total DebtLower is stronger
$373.2M
Stockholders' EquityBook value
$562.0M
$403.5M
Total Assets
$876.7M
$928.3M
Debt / EquityLower = less leverage
0.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNS
CNS
PX
PX
Q4 25
$145.5M
$28.2M
Q3 25
$98.1M
$40.0M
Q2 25
$95.4M
$33.4M
Q1 25
$65.2M
$74.4M
Q4 24
$183.0M
$67.5M
Q3 24
$106.5M
$61.5M
Q2 24
$122.0M
$31.2M
Q1 24
$99.5M
$29.0M
Total Debt
CNS
CNS
PX
PX
Q4 25
$373.2M
Q3 25
$393.4M
Q2 25
$373.0M
Q1 25
$357.2M
Q4 24
$319.8M
Q3 24
$319.4M
Q2 24
$300.6M
Q1 24
$314.0M
Stockholders' Equity
CNS
CNS
PX
PX
Q4 25
$562.0M
$403.5M
Q3 25
$550.3M
$396.8M
Q2 25
$528.5M
$388.9M
Q1 25
$507.7M
$374.3M
Q4 24
$511.7M
$386.9M
Q3 24
$491.0M
$394.1M
Q2 24
$463.2M
$396.9M
Q1 24
$378.9M
$400.1M
Total Assets
CNS
CNS
PX
PX
Q4 25
$876.7M
$928.3M
Q3 25
$801.6M
$936.0M
Q2 25
$751.0M
$932.2M
Q1 25
$834.9M
$877.4M
Q4 24
$812.4M
$869.3M
Q3 24
$727.8M
$857.0M
Q2 24
$784.1M
$823.2M
Q1 24
$680.7M
$832.8M
Debt / Equity
CNS
CNS
PX
PX
Q4 25
0.93×
Q3 25
0.99×
Q2 25
0.96×
Q1 25
0.95×
Q4 24
0.83×
Q3 24
0.81×
Q2 24
0.76×
Q1 24
0.78×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNS
CNS
PX
PX
Operating Cash FlowLast quarter
$-120.4M
$23.0M
Free Cash FlowOCF − Capex
$-126.4M
$18.1M
FCF MarginFCF / Revenue
-87.9%
22.3%
Capex IntensityCapex / Revenue
4.2%
6.0%
Cash ConversionOCF / Net Profit
-3.45×
2.43×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M
$14.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNS
CNS
PX
PX
Q4 25
$-120.4M
$23.0M
Q3 25
$55.1M
$-8.6M
Q2 25
$-67.6M
$13.4M
Q1 25
$-108.9M
$-4.7M
Q4 24
$96.7M
$101.0M
Q3 24
$25.6M
$27.5M
Q2 24
$31.4M
$34.8M
Q1 24
$4.9M
$11.0M
Free Cash Flow
CNS
CNS
PX
PX
Q4 25
$-126.4M
$18.1M
Q3 25
$52.6M
$-9.5M
Q2 25
$-69.8M
$11.6M
Q1 25
$-110.0M
$-6.0M
Q4 24
$85.0M
$96.6M
Q3 24
$24.2M
$25.2M
Q2 24
$27.1M
$33.9M
Q1 24
$537.0K
$10.7M
FCF Margin
CNS
CNS
PX
PX
Q4 25
-87.9%
22.3%
Q3 25
37.1%
-12.6%
Q2 25
-51.3%
15.9%
Q1 25
-81.8%
-8.9%
Q4 24
60.8%
113.6%
Q3 24
18.2%
34.0%
Q2 24
22.3%
47.7%
Q1 24
0.4%
16.2%
Capex Intensity
CNS
CNS
PX
PX
Q4 25
4.2%
6.0%
Q3 25
1.8%
1.2%
Q2 25
1.6%
2.5%
Q1 25
0.8%
1.9%
Q4 24
8.3%
5.2%
Q3 24
1.1%
3.0%
Q2 24
3.5%
1.3%
Q1 24
3.5%
0.4%
Cash Conversion
CNS
CNS
PX
PX
Q4 25
-3.45×
2.43×
Q3 25
1.32×
-4.01×
Q2 25
-1.84×
3.96×
Q1 25
-2.74×
-1.05×
Q4 24
2.11×
19.12×
Q3 24
0.65×
19.54×
Q2 24
0.99×
4.98×
Q1 24
0.14×
2.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNS
CNS

Segment breakdown not available.

PX
PX

Management Fees$78.1M96%
Advisory Fees$1.8M2%

Related Comparisons